Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000919574-25-007210
Filing Date
2025-11-28
Accepted
2025-11-28 17:33:09
Documents
3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 26570
2 d12048503_ex99-a.htm EX-99 12024
3 d12048503_ex99-b.htm EX-99 18395
  Complete submission text file 0000919574-25-007210.txt   58846
Mailing Address 2 TOWER PLACE SUITE 2000 SOUTH SAN FRANCISCO CA 94080
Business Address 2 TOWER PLACE SUITE 2000 SOUTH SAN FRANCISCO CA 94080 6502666000
STANDARD BIOTOOLS INC. (Subject) CIK: 0001162194 (see all company filings)

EIN.: 770513190 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-86635 | Film No.: 251536581
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)

Mailing Address 1350 AVENUE OF THE AMERICAS SUITE 2600 NEW YORK NY 10019
Business Address 1350 AVENUE OF THE AMERICAS SUITE 2600 NEW YORK NY 10019 212.300.5575
Casdin Capital, LLC (Filed by) CIK: 0001534261 (see all company filings)

EIN.: 800752351 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A